• FirefoxInstall the new Firefox »
  •  Dow Up0.21% Nasdaq Up0.32%

    Novavax, Inc. (NVAX)

    8.94 Up 0.11(1.25%) Mar 5, 4:00PM EST
    Add to Portfolio
    ProfileGet Profile for:
    Novavax, Inc.
    20 Firstfield Road
    Gaithersburg, MD 20878
    United States - Map
    Phone: 240-268-2000
    Website: http://www.novavax.com

    Index Membership:N/A
    Full Time Employees:308

    Business Summary 

    Novavax, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing recombinant protein nanoparticle vaccines and adjuvants. The company’s vaccine technology platform is based on proprietary recombinant nanoparticle vaccine technology that includes virus-like particles vaccines and protein nanoparticle vaccines. Its vaccine candidates target seasonal influenza, pandemic influenza, and respiratory syncytial virus. The company also develops technology for the production of immune stimulating saponin-based adjuvants. Novavax, Inc. has a clinical development agreement with PATH Vaccine Solutions to develop RSV vaccine candidate. The company was founded in 1987 and is headquartered in Gaithersburg, Maryland.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Novavax, Inc.

    Corporate Governance 
    Novavax, Inc.’s ISS Governance QuickScore as of Mar 1, 2015 is 8. The pillar scores are Audit: 1; Board: 6; Shareholder Rights: 8; Compensation: 9.
    Brought to you by Institutional Shareholder Services (ISS)

    Key Executives 
    Mr. Stanley C. Erck , 67
    Chief Exec. Officer, Pres, Director and Member of Fin. Committee
    Mr. Barclay A. Phillips , 52
    Chief Financial Officer, Principal Accounting Officer, Sr. VP and Treasurer
    Dr. Gregory M. Glenn M.D., 61
    Sr. VP of Corp. Devel.
    Dr. Timothy Jon Hahn Ph.D., 51
    Sr. VP of Global Manufacturing Operations
    Mr. John Joseph Trizzino B.S., M.B.A., 55
    Sr. VP of Commercial Operations
    Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders